Curated News
By: NewsRamp Editorial Staff
May 09, 2024
Triomics Raises $15M to Automate Oncology Workflows with GenAI-Powered Platform
TLDR
- Triomics has raised $15M to streamline oncology workflows, giving cancer centers an advantage in processing patient health records at scale.
- Triomics applies generative AI and OncoLLM™ to process oncology data, finding 90% of eligible patients for clinical trials in minutes.
- Triomics' technology aims to improve patient care by automating clinical trials, matching patients to care pathways, and streamlining cancer center workflows.
- Triomics co-founders, Sarim Khan and Hrituraj Singh, leveraged generative AI to develop OncoLLM™ for oncology-specific use cases, revolutionizing cancer care.
Impact - Why it Matters
The news is important because it highlights the innovative use of generative AI to help cancer centers efficiently process oncology data, match patients to clinical trials, and improve the overall quality of care. This impacts cancer patients, healthcare providers, and researchers by potentially reducing clinical delays, improving patient care, and advancing precision oncology.
Summary
Triomics has raised $15M to help cancer centers streamline workflows and process oncology data at scale using their OncoLLM™ language models and use case-specific software. The company's co-founders, Sarim Khan and Hrituraj Singh, leveraged generative AI to build tailored models specifically for oncology, resulting in quicker patient-trial matching and improved quality reporting.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Triomics Raises $15M to Automate Oncology Workflows with GenAI-Powered Platform
